In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

ESC Statement concerning Pre-operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery



Further to the publication of a “Meta-analysis of secure randomised controlled trials of b-blockade to prevent perioperative death in non-cardiac surgery" (1), which refers to the ESC Clinical Practice Guidelines on Pre-operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery, the ESC would like to state the following:
  • The ESC is currently revising these guidelines as announced in a previous statement in March 2013 taking into account this very complex scientific issue
  • The ESC Board is taking these new findings very seriously, keeping patients' best interests at heart
  • The ESC has convened an urgent task force to decide whether further actions are required
  • The ESC, AHA and ACCF are collaborating
The ESC will update these pages as soon as new developments occur (2) .

References


(1) Bouri S, et al. Heart 2013:0:1-9.doi:10.1136/heartjnl-2013-304262
(2) Joint ACCF/AHA/ESC statement